Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-04

Clinical Trial Update: Rapid Administration of Carnitine in sEpsis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing rapid administration of carnitine in septic shock has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carnitine (L-carnitine)

Snippet

Sponsor: University of Mississippi Medical Center | Conditions: Septic Shock | Phase 2 | Status: COMPLETED | Results posted: 2019-06-04